Granulocyte antibodies in leukaemic chronic lymphoproliferative disorders

Br J Haematol. 1987 Aug;66(4):461-5. doi: 10.1111/j.1365-2141.1987.tb01327.x.

Abstract

The anti-granulocyte activity of serum from patients with B-cell chronic lymphocytic leukaemia (CLL) and other lymphoproliferative disorders was investigated. Granulocyte-binding IgG was measured in 34 patients with CLL, 13 patients with hairy cell leukaemia, one patient with prolymphocytic leukaemia, two patients with Sézary cell leukaemia, and seven patients with chronic T-cell lymphocytosis who had a predominance of circulating large granular lymphocytes. Anti-granulocyte activity was absent in CLL and its variants, but present in the majority of granulocytopenic patients with chronic T-cell lymphocytosis. In one of these patients, granulocytopenia was associated with complement-activating IgG granulocyte antibody. Thus, antibody-mediated granulocyte injury appears to be an unusual occurrence in chronic lymphocytic leukaemia, but is a frequent complication of chronic T-cell lymphocytosis.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Autoantibodies / analysis*
  • Chronic Disease
  • Female
  • Granulocytes / immunology*
  • Humans
  • Immunoglobulin G / analysis
  • Leukemia / immunology*
  • Leukemia, Hairy Cell / immunology
  • Leukemia, Lymphoid / immunology
  • Leukocyte Count
  • Lymphoproliferative Disorders / immunology*
  • Male
  • Middle Aged

Substances

  • Autoantibodies
  • Immunoglobulin G